SEC Form 4 · accession 0001127602-18-027485
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline Scanlan
Officer — SVP, Global Human Resources
Period of report
Sep 10, 2018
Accepted (ET)
Sep 12, 2018 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 10, 2018 | M | 1,299 | $38.43 | A | 7,552 | D | |
| Common StockF2 | Sep 10, 2018 | S | 1,299 | $112.19 | D | 6,253 | D | |
| Common StockF2 | Sep 10, 2018 | M | 2,889 | $41.64 | A | 9,142 | D | |
| Common StockF2 | Sep 10, 2018 | S | 2,889 | $112.19 | D | 6,253 | D | |
| Common StockF2 | Sep 10, 2018 | S | 702 | $112.19 | D | 5,551 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F3 | $38.43 | Sep 10, 2018 | M | 1,299 | D | Mar 6, 2018 | Mar 6, 2024 | Common Stock | 1,299 | 3,898 | D |
| Non-qualified Stock Option (Right to Buy)F3 | $41.64 | Sep 10, 2018 | M | 2,889 | D | Jun 6, 2018 | Jun 6, 2024 | Common Stock | 2,889 | 8,669 | D |
Explanation of responses
- F1Transaction pursuant to an existing 10b5-1 trading plan.
- F2This number includes unvested restricted stock units previously reported.
- F3Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.